A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2022
This article has no abstract
Epistemonikos ID: 411d6dffe28a96c484cb7dfa9dbfc6db549e60eb
First added on: Mar 21, 2025